ModerateCardiovascularHeart failure with reduced ejection fractionuk-plab-1
A 75-year-old woman with ischaemic heart disease and reduced left ventricular ejection fraction (30%) presents to clinic with exertional dyspnoea and ankle swelling. She is already on Ramipril 10 mg daily and Furosemide 40 mg daily. Her blood pressure is 120/70 mmHg and renal function is stable. According to UK guidance, which drug class should be added next to improve prognosis?